Page last updated: 2024-08-25

alacepril and Heart Failure

alacepril has been researched along with Heart Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hisatome, I; Igawa, O; Kato, M; Kinugawa, T; Ogino, K; Osaki, S; Shigemasa, C; Shimoyama, M; Tomikura, Y1
Cheung, B1
Jougasaki, M; Kato, H; Kikuta, K; Nakao, K; Sumida, H; Tanaka, H; Yasue, H; Yoshimura, M1
Endo, A; Hamada, T; Hisatome, I; Kato, M; Kato, T; Kinugawa, T; Miyakoda, H; Mori, M; Noguchi, N; Ogino, K; Omodani, H; Osaki, S; Shigemasa, C1
Furuse, Y; Igawa, O; Kato, M; Kinugawa, T; Ogino, K; Osaki, S; Shigemasa, C; Tomikura, Y1

Trials

3 trial(s) available for alacepril and Heart Failure

ArticleYear
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    British heart journal, 1994, Volume: 72, Issue:6

    Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Wedge Pressure; Time Factors; Vascular Resistance

1994
Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    European journal of clinical pharmacology, 1998, Volume: 54, Issue:3

    Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; Body Weight; Captopril; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Renin; Tilt-Table Test; Ventricular Function, Left

1998
Effects of acute and chronic alacepril treatment on exercise capacity and hemodynamics in patients with heart failure: a preliminary study.
    International journal of clinical pharmacology and therapeutics, 2002, Volume: 40, Issue:2

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption

2002

Other Studies

2 other study(ies) available for alacepril and Heart Failure

ArticleYear
Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:12

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross-Over Studies; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents; Patients; Statistics, Nonparametric

2002
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    British heart journal, 1995, Volume: 73, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Heart Failure; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins

1995